Testicular cancer
relatively rare and accounts for 1-1.5% of male cancers
it is rare before puberty but is the most common tumour in young and middle aged men (usually in males between the ages of 15-49)
- Testicular tumours can be divided into:
- germ cell tumours (GCTs)
- 90-95% of testicular tumours
- e.g. – Seminoma, Spermatocytic seminoma
- considered a curable cancer owing to the >95% cure rate in all patients
- 90% cure rate in patients with metastatic disease
- lymphomas
- about 4% of testicular tumours
- almost always found in men aged over 50 years
- generally treated as a different disease entity from GCTs
- cord stromal tumours
- e.g. – Leydig cell tumour, Sertoli cell tumour
- uncommon and usually benign
- rare tumours
- arising in paratesticular structures include rhabdomyosarcomas in children and liposarcomas in older men
- germ cell tumours (GCTs)
- Risk factors
- Cryptorchidism – risk for both the descended and undescended
- Subfertility
- Caucasian
- Family history
- Previous contralateral tumour
- HIV
- Down syndrome
- Clinical
- painless, solid, unilateral mass in the scrotum (majority of cases)
- scrotal pain (20% of cases)
- enlarged testicle, a decrease in testicular size may also occur
- hydrocoele
- metastases:
- metastatic growths in lung resulting in cough, pain or haemoptysis
- abdominal mass and backache due to enlarged para-aortic lymph nodes
- cervical lymphadenopathy
- backache (10%)
- gynaecomastia (7%)
- dragging sensation in the scrotum
- incidental recent trauma (It is not thought that the trauma causes the cancer, but rather that it brings an existing tumour to the attention of the patient and physician)
- painless, solid, unilateral mass in the scrotum (majority of cases)
- Investigations
- USS
- AFP, BHCG, LDH
- CT C/A/P
- Serum testosterone
- LH/FSH – assess testicular failure
- Testicular biopsy, radical orchidectomy
- CT C/A/P, CXR
- Consider sperm banking
- Treatment
- Radical orchidectomy
- Chemotherapy
- Consider psych referral
- Follow up – monitor BHCG AFP, LDH